BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 24450579)

  • 1. Health resource utilization and cost associated with myeloproliferative neoplasms in a large United States health plan.
    Mehta J; Wang H; Fryzek JP; Iqbal SU; Mesa R
    Leuk Lymphoma; 2014 Oct; 55(10):2368-74. PubMed ID: 24450579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Healthcare resource utilization in myeloproliferative neoplasms: a population-based study from Ontario, Canada.
    Bankar A; Zhao H; Iqbal J; Coxford R; Cheung MC; Mozessohn L; Earle CC; Gupta V
    Leuk Lymphoma; 2020 Aug; 61(8):1908-1919. PubMed ID: 32323602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology of myeloproliferative neoplasms in the United States.
    Mehta J; Wang H; Iqbal SU; Mesa R
    Leuk Lymphoma; 2014 Mar; 55(3):595-600. PubMed ID: 23768070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myeloproliferative neoplasms (MPNs) have a significant impact on patients' overall health and productivity: the MPN Landmark survey.
    Mesa R; Miller CB; Thyne M; Mangan J; Goldberger S; Fazal S; Ma X; Wilson W; Paranagama DC; Dubinski DG; Boyle J; Mascarenhas JO
    BMC Cancer; 2016 Feb; 16():167. PubMed ID: 26922064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival patterns in United States (US) medicare enrollees with non-CML myeloproliferative neoplasms (MPN).
    Price GL; Davis KL; Karve S; Pohl G; Walgren RA
    PLoS One; 2014; 9(3):e90299. PubMed ID: 24618579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence, Survival and Prevalence Statistics of Classical Myeloproliferative Neoplasm in Korea.
    Lim Y; Lee JO; Bang SM
    J Korean Med Sci; 2016 Oct; 31(10):1579-85. PubMed ID: 27550486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Healthcare resource utilization in patients with myeloproliferative neoplasms: A Danish nationwide matched cohort study.
    Christensen SF; Svingel LS; Kjaersgaard A; Stenling A; Darvalics B; Paulsson B; Andersen CL; Christiansen CF; Stentoft J; Starklint J; Severinsen MT; Clausen MB; Hilsøe MH; Hasselbalch HC; Frederiksen H; Mikkelsen EM; Bak M
    Eur J Haematol; 2022 Nov; 109(5):526-541. PubMed ID: 35900040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloproliferative neoplasms: trends in incidence, prevalence and survival in Norway.
    Roaldsnes C; Holst R; Frederiksen H; Ghanima W
    Eur J Haematol; 2017 Jan; 98(1):85-93. PubMed ID: 27500783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Myeloproliferative neoplasms on patients' employment status and work productivity in the United States: results from the living with MPNs survey.
    Yu J; Parasuraman S; Paranagama D; Bai A; Naim A; Dubinski D; Mesa R
    BMC Cancer; 2018 Apr; 18(1):420. PubMed ID: 29653557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changing concepts of diagnostic criteria of myeloproliferative disorders and the molecular etiology and classification of myeloproliferative neoplasms: from Dameshek 1950 to Vainchenker 2005 and beyond.
    Michiels JJ; Berneman Z; Schroyens W; De Raeve H
    Acta Haematol; 2015; 133(1):36-51. PubMed ID: 25116092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MERGE: A Multinational, Multicenter Observational Registry for Myeloproliferative Neoplasms in Asia, including Middle East, Turkey, and Algeria.
    Yassin MA; Taher A; Mathews V; Hou HA; Shamsi T; Tuğlular TF; Xiao Z; Kim SJ; Depei W; Li J; Rippin G; Sadek I; Siddiqui A; Wong RS
    Cancer Med; 2020 Jul; 9(13):4512-4526. PubMed ID: 32351024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic burden of irritable bowel syndrome with constipation: a retrospective analysis of health care costs in a commercially insured population.
    Doshi JA; Cai Q; Buono JL; Spalding WM; Sarocco P; Tan H; Stephenson JJ; Carson RT
    J Manag Care Spec Pharm; 2014 Apr; 20(4):382-90. PubMed ID: 24684643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical complications, resource utilization and costs in patients with myelofibrosis by frequency of blood transfusion and iron chelation therapy.
    Vekeman F; Cheng WY; Sasane M; Huynh L; Duh MS; Paley C; Mesa RA
    Leuk Lymphoma; 2015; 56(10):2803-11. PubMed ID: 25676036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Healthcare resource utilization among commercially insured patients with cold agglutinin disease in the United States.
    Su J; Bylsma LC; Jiang X; Morales Arias J; Jain N; Nordyke RJ
    J Med Econ; 2020 Aug; 23(8):902-907. PubMed ID: 32362156
    [No Abstract]   [Full Text] [Related]  

  • 15. Novel hematological parameters for the evaluation of patients with myeloproliferative neoplasms: the immature platelet and reticulocyte fractions.
    Strati P; Bose P; Lyle L; Gaw K; Zhou L; Pierce SA; Huynh-Lu J; Hirsch-Ginsberg CF; Bueso-Mendoza DE; Bueso-Ramos CE; Verstovsek S
    Ann Hematol; 2017 May; 96(5):733-738. PubMed ID: 28247057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic burden of skeletal-related events in patients with multiple myeloma: analysis of US commercial claims database.
    Bhowmik D; Hines DM; Intorcia M; Wade RL
    J Med Econ; 2018 Jun; 21(6):622-628. PubMed ID: 29571273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real world epidemiology of myeloproliferative neoplasms: a population based study in Korea 2004-2013.
    Byun JM; Kim YJ; Youk T; Yang JJ; Yoo J; Park TS
    Ann Hematol; 2017 Mar; 96(3):373-381. PubMed ID: 28028559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changing incidence of myeloproliferative neoplasms: trends and subgroup risk profiles in the USA, 1973-2011.
    Deadmond MA; Smith-Gagen JA
    J Cancer Res Clin Oncol; 2015 Dec; 141(12):2131-8. PubMed ID: 25968903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Healthcare resource utilization and costs by age and joint location among osteoarthritis patients in a privately insured population.
    Wang SX; Ganguli AX; Bodhani A; Medema JK; Reichmann WM; Macaulay D
    J Med Econ; 2017 Dec; 20(12):1299-1306. PubMed ID: 28880733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incremental Healthcare Service Utilization for Open-angle Glaucoma: A Population-Based Study.
    Chung SD; Ho JD; Lin HC; Kao LT; Tsai MC
    J Glaucoma; 2015; 24(5):e116-20. PubMed ID: 25642815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.